Compare ADMA & LGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADMA | LGN |
|---|---|---|
| Founded | 2004 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.6B |
| IPO Year | 2012 | N/A |
| Metric | ADMA | LGN |
|---|---|---|
| Price | $16.31 | $52.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 15 |
| Target Price | $32.00 | ★ $44.90 |
| AVG Volume (30 Days) | ★ 3.1M | 731.1K |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.60 | N/A |
| Revenue | ★ $42,219,783.00 | N/A |
| Revenue This Year | $27.46 | $17.13 |
| Revenue Next Year | $21.11 | $42.76 |
| P/E Ratio | $26.37 | ★ N/A |
| Revenue Growth | ★ 43.85 | N/A |
| 52 Week Low | $13.76 | $28.31 |
| 52 Week High | $25.67 | $58.00 |
| Indicator | ADMA | LGN |
|---|---|---|
| Relative Strength Index (RSI) | 53.14 | 52.00 |
| Support Level | $15.35 | $42.97 |
| Resistance Level | $17.53 | $53.65 |
| Average True Range (ATR) | 0.82 | 2.79 |
| MACD | 0.08 | -0.43 |
| Stochastic Oscillator | 68.97 | 45.00 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
Legence Corp is a provider of engineering, installation and maintenance services for mission-critical systems in buildings. It focuses on high-growth sectors that have technically demanding buildings, including technology, life sciences, healthcare and education. The company specializes in designing, fabricating and installing complex HVAC, process piping and other mechanical, electrical and plumbing (MEP) systems for new facilities and upgrading HVAC, lighting and building controls in existing facilities to make them more energy efficient and sustainable.